The construct and various mutants of human GIPR were cloned into pcDNA3.1 vector for cAMP accumulation and whole-cell binding assays
In the SURMOUNT-OSA trial, tirzepatide reduced the apnea-hypopnea index by up to 62.8%, translating to approximately 30 fewer breathing interruptions per hour of sleep
Provide complete entries for each therapy: drug name, start date, end date (or leave blank if ongoing), outcome, and whether it will be continued
Our team at Southern Care Anesthetics is here to answer your questions, educate you on potential risks, and help you make safe, evidence-based choices about your health
Mar 10, 2026 Tired of conflicting information about why your GLP-1 medication stopped working